Elevated expression of Type 1 T helper cells is known to increase tumor cells’ sensitivity to various treatments, and when combined with clinical parameters like TNM staging and AFP levels, it presents excellent predictability of early HCC recurrence (71). This evidence concerns the gene AFP and hepatocellular carcinoma.